Connect with Co-Founder & CEO, @Jean-Philippe Combal & Director of Regulatory Affairs & Quality Assurance, @Annelise Brossel at the inaugural Cell & Gene Therapy Regulatory Affairs Summit presented by @HansonWade, from 28 – 30 October in 🏦 Washington, D.C.!
Get in touch to schedule a meeting with the team or you can find Jean-Philippe and Anne at the following presentations:
📅 Date: Tuesday 29 October 2024 🕘 Time: 9:00 am EDT
🔥 Fireside Chat: Overcoming Current & Future Regulatory Challenges in the Cell & Gene Therapy Field
📢 Jean-Philippe Combal
📅 Date: Tuesday 29 October 2024 🕘 Time: 13:45 pm EDT
🔥 Panel: Navigating Various Assigned Designations like Orphan, Prime, & More to Clarify Criteria & Distinctions
📢 Jean-Philippe Combal
📅 Date: Wednesday 30 October 2024 🕘 Time: 9:30 am EDT
🔥 Panel: Supercharging Regulatory CMC by Overcoming Challenges to Ensure Safe & Efficacious Advanced Therapies
📢 Annelise Brossel
The #Summit brings together #CGT therapy regulatory experts comprised of C-Level Executives, Vice Presidents, and Directors of regulatory affairs and CMC to delve into all aspects of #CellandGeneTherapy regulation, from pre-IND to post-BLA, to benchmark best practices and prepare for all significant regulatory milestones.
